PRICE T ROWE ASSOCIATES INC /MD/ - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$62
-69.6%
18,195
-34.3%
0.00%
Q2 2023$204
-16.7%
27,690
+17.2%
0.00%
Q1 2023$245
-8.6%
23,631
+4.0%
0.00%
Q4 2022$268
-100.0%
22,717
-19.3%
0.00%
Q3 2022$592,000
-85.7%
28,139
-78.8%
0.00%
-100.0%
Q2 2022$4,126,000
-60.1%
132,927
-47.2%
0.00%0.0%
Q1 2022$10,334,000
-12.6%
251,689
-7.5%
0.00%0.0%
Q4 2021$11,827,000
-56.3%
272,073
-49.7%
0.00%
-66.7%
Q3 2021$27,065,000
-22.4%
540,549
-2.4%
0.00%0.0%
Q2 2021$34,899,000
-51.5%
554,036
-28.5%
0.00%
-57.1%
Q1 2021$72,010,000
-7.9%
775,054
-11.2%
0.01%
-12.5%
Q4 2020$78,164,000
-14.6%
872,367
-1.5%
0.01%
-27.3%
Q3 2020$91,527,000
+32.4%
885,771
+1.3%
0.01%
+22.2%
Q2 2020$69,148,000
+35.3%
874,402
-1.0%
0.01%
+12.5%
Q1 2020$51,123,000
+6.6%
883,570
-0.6%
0.01%
+33.3%
Q4 2019$47,980,000
+5.4%
889,339
+2.2%
0.01%0.0%
Q3 2019$45,511,000
+15.8%
870,528
+7.0%
0.01%0.0%
Q2 2019$39,287,000
-4.7%
813,233
-0.3%
0.01%0.0%
Q1 2019$41,207,000
-9.2%
815,657
+6.6%
0.01%
-25.0%
Q4 2018$45,364,000
-5.7%
765,254
+4.7%
0.01%
+14.3%
Q3 2018$48,106,000
+55.6%
730,762
+19.3%
0.01%
+40.0%
Q2 2018$30,925,000
+76.2%
612,489
+83.8%
0.01%
+66.7%
Q1 2018$17,547,000
+2562.7%
333,282
+2248.7%
0.00%
Q4 2017$659,000
+14.8%
14,190
-0.1%
0.00%
Q3 2017$574,000
+19.1%
14,2000.0%0.00%
Q2 2017$482,000
+17.0%
14,200
+0.1%
0.00%
Q1 2017$412,000
-11.6%
14,190
+0.1%
0.00%
Q4 2016$466,000
+47.9%
14,180
+42.1%
0.00%
Q3 2016$315,000
+21.2%
9,980
-27.0%
0.00%
Q3 2013$260,00013,6730.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders